Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort.
Marco H JiNatalia F CallawayMargaret A GrevenDaniel VailDarius M MoshfeghiPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.
Keyphrases
- end stage renal disease
- newly diagnosed
- vascular endothelial growth factor
- ejection fraction
- chronic kidney disease
- diabetic retinopathy
- prognostic factors
- ultrasound guided
- age related macular degeneration
- metastatic colorectal cancer
- patient reported outcomes
- aortic dissection
- patient reported
- network analysis